|Bid||29.88 x 1100|
|Ask||30.76 x 1000|
|Day's Range||29.83 - 31.41|
|52 Week Range||3.57 - 53.69|
|Beta (5Y Monthly)||1.12|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
PacBio's (PACB) latest acquisition is expected to deliver the most advanced blend of sequencing solutions to transform the genomics landscape.
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Pacific Biosciences' (PACB) latest research tie-up is likely to use HiFi Sequencing data on some of the most difficult cases of rare pediatric disease and provide insights into the treatment journey.